Literature DB >> 14634291

CD14 and apoptosis.

C D Gregory1, A Devitt.   

Abstract

In addition to its role as a mediator of innate pro-inflammatory responses following bacterial lipopolysaccharide (LPS) binding, the 55kDa glycosyl-phosphatidylinositol-linked macrophage plasma membrane glycoprotein CD14 is now also known to play a role in phagocytic clearance of apoptotic cells. Although apoptotic cell-associated ligand(s) for CD14 await definition, initial findings suggest that ligand binding occurs close to, or at the same site as, LPS binding. Significantly, in contrast to LPS clearance and in keeping with the non-phlogistic nature of apoptosis, CD14-dependent engulfment of apoptotic cells fails to elicit pro-inflammatory cytokine release from macrophages. Therefore CD14 may be regarded as an innate immune receptor both for microbial products--after binding which activates inflammatory responses--and for self components, which either fail to induce, or alternatively actively suppress, inflammatory responses. Here we review current knowledge of the structure and functions of CD14, its ligands, its possible modes of signal transduction and its place in the panoply of macrophage molecules implicated in apoptotic-cell clearance.

Entities:  

Year:  1999        PMID: 14634291     DOI: 10.1023/a:1009673914340

Source DB:  PubMed          Journal:  Apoptosis        ISSN: 1360-8185            Impact factor:   4.677


  10 in total

Review 1.  The macrophage and the apoptotic cell: an innate immune interaction viewed simplistically?

Authors:  Christopher D Gregory; Andrew Devitt
Journal:  Immunology       Date:  2004-09       Impact factor: 7.397

2.  MCP-1-activated monocytes induce apoptosis in human retinal pigment epithelium.

Authors:  Dongli Yang; Susan G Elner; Xun Chen; Matthew G Field; Howard R Petty; Victor M Elner
Journal:  Invest Ophthalmol Vis Sci       Date:  2011-07-29       Impact factor: 4.799

3.  Tumour necrosis factor alpha (TNF)-TNF receptor 1-inducible cytoprotective proteins in the mouse liver: relevance of suppressors of cytokine signalling.

Authors:  Gabriele Sass; Noula D Shembade; Gisa Tiegs
Journal:  Biochem J       Date:  2005-01-15       Impact factor: 3.857

4.  Impaired apoptotic cell clearance in CGD due to altered macrophage programming is reversed by phosphatidylserine-dependent production of IL-4.

Authors:  Ruby F Fernandez-Boyanapalli; S Courtney Frasch; Kathleen McPhillips; R William Vandivier; Brian L Harry; David W H Riches; Peter M Henson; Donna L Bratton
Journal:  Blood       Date:  2008-10-24       Impact factor: 22.113

5.  CD14 and toll-like receptors 2 and 4 are required for fibrillar A{beta}-stimulated microglial activation.

Authors:  Erin G Reed-Geaghan; Julie C Savage; Amy G Hise; Gary E Landreth
Journal:  J Neurosci       Date:  2009-09-23       Impact factor: 6.167

6.  Genetic evidence of a functional monocyte dichotomy.

Authors:  James L Mobley; Michael Leininger; Steven Madore; Theodore J Baginski; Richard Renkiewicz
Journal:  Inflammation       Date:  2007-06-21       Impact factor: 4.092

7.  In vitro effects of emodin on peritoneal macrophage intercellular adhesion molecule-3 in a rat model of severe acute pancreatitis/systemic inflammatory response syndrome.

Authors:  Qingqiang Ni; Wei Zhang; Kang Sun; Chao Yin; Jizhong An; Dong Shang
Journal:  Biomed Rep       Date:  2013-10-03

8.  Apoptosis of human lymphocytes after exposure to hydatid fluid.

Authors:  M Mokhtari Amirmajdi; M Sankian; I Eftekharzadeh Mashhadi; A Varasteh; F Vahedi; A Sadrizadeh; A Spotin
Journal:  Iran J Parasitol       Date:  2011-06       Impact factor: 1.012

9.  Heterogeneous in vitro effects of doxorubicin on gene expression in primary human liposarcoma cultures.

Authors:  Adrien Daigeler; Ludger Klein-Hitpass; Michael Ansgar Chromik; Oliver Müller; Jörg Hauser; Heinz-Herbert Homann; Hans-Ulrich Steinau; Marcus Lehnhardt
Journal:  BMC Cancer       Date:  2008-10-29       Impact factor: 4.430

10.  Development of highly organized lymphoid structures in Buruli ulcer lesions after treatment with rifampicin and streptomycin.

Authors:  Daniela Schütte; Alphonse Um-Boock; Ernestina Mensah-Quainoo; Peter Itin; Peter Schmid; Gerd Pluschke
Journal:  PLoS Negl Trop Dis       Date:  2007-10-31
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.